Grow Your Wealth
with Mutual Funds
Mirae Asset Nifty 500 Healthcare Etf-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 7.6 Cr.
NAV as on 27 jul, 2026
₹ 21.32
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Mirae Asset Nifty 500 Healthcare Etf-growth
Inception Date
10 Feb 2026
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
99.90%
Cash
0.10%
Portfolio Updated on: 13 Jul, 2026
Sector Allocations
Equity
Healthcare
Portfolio Updated on: 27 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 1.00% |
| Divi's Laboratories Ltd | Healthcare | Equity | 1.00% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 1.00% |
| Cipla Ltd | Healthcare | Equity | 1.00% |
| Divi's Laboratories Ltd | Healthcare | Equity | 1.00% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 1.00% |
Debt & Credit Risk Analysis
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 11.84% | NA | 6.12% |
Mirae Asset Nifty 500 Healthcare Etf-growth is one Equity mutual fund offered by Mirae Asset Mutual Fund. Launched on 10 Feb 2026, the fund aims Return that are commensurate with the performance of Nifty 500 Healthcare Total Return Index,subject to tracking error over long term.investment in securities constituting in Nifty 500 healthcare total Return Index. It manages assets worth ₹7.6 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.11%.
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Mirae Asset Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Mirae Asset Healthcare Fund Direct-growth | 2,753.7 | +4.50% | +11.69% | +24.64% | +14.57% | +23.36% | +16.17% |
| Mirae Asset Healthcare Fund Regular-growth | 2,753.7 | +4.37% | +11.29% | +23.75% | +12.93% | +21.58% | +14.46% |
| Mirae Asset Healthcare Fund Regular-idcw | 2,753.7 | +4.37% | +11.29% | +23.75% | +12.93% | +21.58% | +14.46% |
| Mirae Asset Healthcare Fund Direct-idcw | 2,753.7 | +4.50% | +11.69% | +24.64% | +14.57% | +23.36% | +16.17% |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.15 | +24.11% | +17.02% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.47 | +24.11% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹506.05 | +22.55% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹318.78 | +22.55% | +17.02% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹50.72 | +23.36% | +16.17% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹30.55 | +23.36% | +16.17% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 27 Jul 2026 | ₹21.32 |
| 24 Jul 2026 | ₹20.98 |
| 23 Jul 2026 | ₹21.04 |
| 22 Jul 2026 | ₹21.17 |
| 21 Jul 2026 | ₹21.43 |
| 20 Jul 2026 | ₹21.37 |
| 17 Jul 2026 | ₹21.13 |
| 16 Jul 2026 | ₹21.38 |
| 15 Jul 2026 | ₹21.40 |
| 14 Jul 2026 | ₹21.30 |
| 13 Jul 2026 | ₹21.16 |
| 10 Jul 2026 | ₹21.17 |
| 09 Jul 2026 | ₹21.11 |
| 08 Jul 2026 | ₹20.90 |
| 07 Jul 2026 | ₹21.14 |
| 06 Jul 2026 | ₹21.30 |
| 03 Jul 2026 | ₹21.28 |
| 02 Jul 2026 | ₹20.98 |
| 01 Jul 2026 | ₹20.85 |
| 30 Jun 2026 | ₹20.93 |
| 29 Jun 2026 | ₹20.83 |
| 25 Jun 2026 | ₹20.63 |
| 24 Jun 2026 | ₹20.62 |
| 23 Jun 2026 | ₹20.59 |
| 22 Jun 2026 | ₹20.45 |
| 19 Jun 2026 | ₹20.29 |
| 18 Jun 2026 | ₹20.14 |
| 17 Jun 2026 | ₹19.93 |
| 15 Jun 2026 | ₹20.01 |
| 12 Jun 2026 | ₹20.13 |
Portfolio Updated on: 28 Jul, 2026
Fund Growth & Size Analysis
+₹7.6 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Mirae Asset Nifty 500 Healthcare Etf-growth Returns Comparison
Compare Mirae Asset Nifty 500 Healthcare Etf-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Mirae Asset Nifty 500 ....
No funds found for your search.
